McKesson Corporation McKesson Corporation

McKesson Corporation

MCK

Classificação em ações #187
McKesson Corporation is a prominent global provider of healthcare services,... McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Preço da ação
$1,023.06
Valor de mercado
$119.28B
Variação (1 dia)
1.13%
Variação (1 ano)
29.86%
País
US
Negociar McKesson Corporation (MCK)

Categoria

Healthcare
Rácio P/E de McKesson Corporation (MCK)
Rácio P/E em October 2026 TTM: 26.02
De acordo com os últimos relatórios financeiros e o preço das ações da McKesson Corporation, o rácio P/E atual (TTM) é 26.02. No final de 2024, a empresa tinha um P/E de 23.80.
Histórico do rácio P/E da McKesson Corporation de 2000 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
2026 (TTM) 26.02 0.00%
2025 26.02 9.31%
2024 23.80 68.68%
2023 14.11 -66.28%
2022 41.85 -706.47%
2021 -6.90 -125.37%
2020 27.20 -96.04%
2019 686.13 56.89%
2018 437.33 6,817.88%
2017 6.32 -60.53%
2016 16.02 -54.95%
2015 35.55 11.06%
2014 32.01 68.89%
2013 18.96 23.18%
2012 15.39 -14.73%
2011 18.05 28.94%
2010 14.00 19.55%
2009 11.71 -23.94%
2008 15.39 -15.02%
2007 18.12 -16.19%
2006 21.61 -130.58%
2005 -70.69 -623.74%
2004 13.50 3.94%
2003 12.99 -49.58%
2002 25.75 -116.43%
2001 -156.79 -2,020.83%
2000 8.16 0.00%
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
- -
US
34.08 30.96%
US
- -
US
45.62 75.31%
AU
24.73 -4.97%
US
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.